TherapeuticsMD
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $952 | $393 | $667 | $547 |
Gross Profit | 856 | 393 | 667 | 547 |
EBITDA | 643 | -571 | -974 | -474 |
EBIT | 547 | -666 | -1,074 | -570 |
Net Income | 551 | -653 | 252 | -609 |
Net Change In Cash | 952 | 393 | 667 | 547 |
Free Cash Flow | 381 | 699 | 17 | -71 |
Cash | 6,069 | 5,745 | 5,059 | 5,047 |
Basic Shares | 11,574 | 11,552 | 11,532 | 11,532 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,761 | $1,302 | $69,963 | $86,951 |
Gross Profit | 1,761 | 380 | 68,566 | 68,113 |
EBITDA | -2,983 | -8,401 | 11,856 | -78,569 |
EBIT | -3,492 | -9,323 | 10,663 | -79,305 |
Net Income | -2,181 | -10,278 | 111,997 | -205,604 |
Net Change In Cash | 1,761 | 1,302 | 69,963 | 86,951 |
Cost of Revenue | -15,364 | |||
Free Cash Flow | 1,170 | -48,141 | -4,433 | -144,916 |
Cash | 5,059 | 4,327 | 38,067 | 65,122 |
Basic Shares | 11,532 | 10,441 | 9,028 | 7,960 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.05 |
2025-03-31 | $0.02 |
2024-12-31 | $0.02 |
